Prospective Cohort Study Evaluating 18FDG-PET for the Early Prediction of Efficacy of Immunotherapy Combined with Chemotherapy in Patients with Non-Small Cell Non-Small Cell Broncho-Pulmonary Carcinoma or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma

Description:

The hypothesis of this prospective observational pilot study of diagnostic diagnostic performance is that, for patients with NSCLC treated with immunotherapy associated with chemotherapy, certain metabolic biomarkers on 18FDG PET scans allow early identification of treatment response (or lack of response to treatment) and optimize prediction of tumor response compared with current standards.